Cara Care for Doctors

A digital solution for evidence-based, holistic IBS care. Doctors in Germany can prescribe it to their patients.

Book a session

Overview

What is Cara Care for IBS?

Digital support for your IBS patients.

Basics

Cara Care for IBS is a CE-certified class 1 medical device offering digital support for people who have IBS.

12-Week Program

Cara Care for IBS combines dietary intervention, mental health programs, GI drug management, and exercise therapy in an easy-to-use mobile application.

App auf Rezept

Doctors in Germany can prescribe Cara Care for IBS to their patients in accordance with the Digital Health Act (DVG) from Winter 2021.

Science

Cara Care for IBS is based on the latest guidelines for IBS management and developed by a team of doctors and medical advisors in gastroenterology.

Active ingredients

Low-FODMAP diet
Cognitive-behavioral therapy principles
Gut-directed hypnosis

Download information material

At a glance

Care principles

Our digital IBS therapy is based on 5 care principles.

Tracking food, symptoms, and medical data (1)

Dietary change (2)

Education (3)

Behavioral change (4)

Audio-guided hypnosis (5)

Learn more

Prescription

How to prescribe Cara Care in Germany

4 simple steps.

Use your normal prescription system.

Search for the keyword CARACARE.

Give your patient the prescription. Ask him/her to go to our website, cara.care. Prescribing the Cara Care digital health application is an extrabudgetary service.

We help the patient get reimbursed and start their customized program.

Flyers

Request flyers

We are happy to send you flyers for your practice. Fill out the form below, or contact us directly at hello@cara.care.

Request Download Cara Care

Your information will not be shared with third parties. Read our Privacy Policy

Ergebnisse

Our outcomes

We’ve published first results that indicate the effectiveness of our tailored programs.

45.4%

Overall symptom reduction in 100 days

22%

Improvement in quality of life

78.8%

Show a clinically significant improvement of their symptoms

View the Paper (German)

Advantages

Advantages of prescribing Cara Care for IBS

Enhance the patient-physician relationship.

Easily accessible to patients

With a 78.8% treatment success rate (6)

Saves time at office visits

Using validated questionnaires, we record the disease-related symptom severity and quality of life and their development in the course of therapy. The results can be presented to you in the form of a data export from your patient.

Expands IBS management toolkit

Cara Care adds guideline-recommended nutrition, mental health, and exercise therapies to your patient’s plan.

Safety

We meet the highest standards for digital healthcare.

CE-certified

GDPR compliant

Transferred encrypted health data

Healthcare Made in Germany

Physician testimonials

Das sagen Fachexpertinnen und Fachexperten

Reduced quality of life and work impairment is a substantial problem in patients suffering with IBS. Somatic symptoms combined with psychological factors influence patients’ ability to be present, active and productive at work. Cara Care’s multidimensional innovative treatment approach is a convenient and effective method of treating patients with IBS.

Professor Anthony Lembo M.D.

Cara Care Scientific Advisory Board and Professor of Medicine at Harvard Medical School

Irritable bowel syndrome is a complex functional disease with various individual triggers, which means that approaching it holistically can lead to better results. I believe that digital tools, combined with medicines, can help deliver better outcomes by improving compliance and helping patients make crucial lifestyle changes.

Prof. Dr. med. Stefan Lüth

Klinikdirektor und Chefarzt am Klinikum Brandenburg Hochschulkoordinator an der Medizinischen Hochschule Brandenburg

Professor Anthony Lembo M.D.

Cara Care Scientific Advisory Board and Professor of Medicine at Harvard Medical School

Prof. Dr. med. Stefan Lüth

Klinikdirektor und Chefarzt am Klinikum Brandenburg Hochschulkoordinator an der Medizinischen Hochschule Brandenburg

Professor Anthony Lembo M.D.

Cara Care Scientific Advisory Board and Professor of Medicine at Harvard Medical School

Prof. Dr. med. Stefan Lüth

Klinikdirektor und Chefarzt am Klinikum Brandenburg Hochschulkoordinator an der Medizinischen Hochschule Brandenburg

Your questions, answered

Which patients should use Cara Care for IBS?

Patients who have been diagnosed with IBS and who do not have contraindications are eligible to use the program.

For a list of contraindications, see the Zweckbestimmung (PDF).

How do I monitor my patients’ progress?

How do I describe the program to the patient and guide them through it?

How is the health data of my patients protected?

What are the risks in prescribing a DiGA?

Does the prescription burden my budget?

References

Expand the list to view the references present in this page.